With regards to HIF-2α, it was observed that patients with Chuvash polycythemia showed HIF-2α gain-of-function mutations associated with PAH development and symptoms such as elevated heart rate and pulmonary ventilation related to metabolic aberrations (40–42). Here, EPAS1 is linked to pulmonary arterial hypertension.